LILIVERA Hair Regrowth Kit 5 g/100mL
Minoxidil · LIQUID · Guangzhou Haishi Biological Technology Co., Ltd.
LILIVERA Hair Regrowth Kit is a liquid containing minoxidil at 5 g/100mL, taken topical. Manufactured by Guangzhou Haishi Biological Technology Co., Ltd..
Key Facts
- Brand Name
- LILIVERA Hair Regrowth Kit
- Generic Name
- Minoxidil
- NDC Code (Product)
60771-0012- Manufacturer
- Guangzhou Haishi Biological Technology Co., Ltd.
- Strength
- 5 g/100mL
- Dosage Form
- LIQUID
- Route
- TOPICAL
- Marketing Status
- Application #
- M032
- Drug Class
- Arteriolar Vasodilator [EPC]
- Marketing Start
- 04/18/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is LILIVERA Hair Regrowth Kit used for?
LILIVERA Hair Regrowth Kit contains Minoxidil. It is a liquid taken topical. Consult your doctor for specific uses.
Is LILIVERA Hair Regrowth Kit a controlled substance?
LILIVERA Hair Regrowth Kit is not classified as a controlled substance by the DEA.
What is the generic name for LILIVERA Hair Regrowth Kit?
The generic name for LILIVERA Hair Regrowth Kit is Minoxidil. There are 12 other brand versions of Minoxidil.
What is the NDC code for LILIVERA Hair Regrowth Kit 5 g/100mL?
The NDC (National Drug Code) for LILIVERA Hair Regrowth Kit 5 g/100mL is 60771-0012, listed by Guangzhou Haishi Biological Technology Co., Ltd..
Other Minoxidil Brands
See all →- Minoxidil2.5 mg/172162-1489
- Minoxidil (for Women)50 mg/g80855-201
- Santo Remedio Mens Hair Regrowth Treatment Minoxidil Topical Solution Extra Strength Unscented50 mg/mL81352-560
- Remixdil Extra Strength hair regrowth treatment for Men5 g/100mL83004-008
- Hair-Regen Hair Growth Treatment5 g/100mL84232-011
- 5%Minoxidil Hair Growth Serum.3 g/100mL84355-003
- Kweqdsd 5% Minoxidil Hair Growth Sprays Serum.5 g/100mL85304-003
- FRNOIP 5% Minoxidil Hair Growth Sprays Serum.5 g/100mL85304-004
- Sidinox 5% Minoxidil Hair Growth Sprays Serum.5 g/100mL85304-007
- 5% minoxidil with biotin topical solution.5 g/100mL85304-021
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)